New hope for advanced cancer: experimental drug CR-001 enters human trials
Disease control
Recruiting now
This study tests a new drug called CR-001 in adults with advanced solid tumors that have spread. The goal is to find the safest dose and see if it can shrink tumors. About 290 people will take part in this early-phase trial.
Phase: PHASE1, PHASE2 • Sponsor: Crescent Biopharma, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC